Global Digital Pathology Market size is predicted to reach $2.4 billion by 2030, growing at a CAGR of 13.1% during the forecast period 2023-2030 according to the latest market research report published by IndustryARC. The increasing prevalence of chronic diseases such as cancer, the growing demand for advanced health care solutions, and the need for effective diagnosis and treatment methods are poised to propel the market growth, finds IndustryARC in its recent report, titled “Digital Pathology Market Size, Share & Trends Analysis Report By Type (Human Pathology, Veterinary Pathology), By Product Type (Scanners, Software, Communication Systems, Storage Systems, Others), By Application(Disease Diagnosis, Research and Education, Drug Discovery and Development), By End Use (Hospitals, Pharmaceutical and Biotech Companies, Research Centers, Others), By Region and Segment Forecasts, 2023–2030”.
Request Sample Research Report:
https://www.industryarc.com/pdfdownload.php?id=16354
Asia-Pacific to Register the Highest Growth:
The Asia Pacific region has been rapidly developing its healthcare infrastructure, with many countries investing heavily in health care facilities and services. This growth in health care infrastructure is expected to increase the adoption of digital pathology solutions.
Additionally, The Asia Pacific region has a strong focus on technological advancements, particularly in countries like Japan, South Korea, and China. These advancements are driving the development of innovative digital pathology solutions, which are expected to increase the adoption of digital pathology in the region. For instance, the NanoZoomer Slide scanner systems, a product of Hamamatsu Photonics KK converts glass slides into high-resolution digital data by high-speed scanning.
Digital Pathology Market 2023-2030: Scope of the Report
| Report Metric | Details |
| Base Year Considered | 2022 |
| Forecast Period | 2023–2030 |
| CAGR | 13.1% |
| Market Size in 2030 | $2.4 billion |
| Segments Covered | Type, Product, Application, End-Use and Region |
| Geographies Covered | North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa). |
| Key Market Players | 1. Danaher Corporation 2. Koninklijke Philips N.V. 3. F. Hoffmann-La Roche Ltd. 4. Nikon Corporation 5. 3DHistech Ltd. 6. Mikroscan Technologies Inc. 7. Hamamatsu Photonics KK 8. Indica Labs Inc. 9. Visiopharm A/S 10. Huron Technologies International, Inc. |
Get Access to Full Research Report: https://www.industryarc.com/Report/16354/digital-pathology-market.html
Digital Pathology Market Report – Key Takeaways:
Storage Systems is analyzed to grow with the highest CAGR of 14.1% during the forecast period. With the increasing adoption of digital pathology workflows, there is a growing volume of digital pathology data that needs to be stored securely and efficiently.
Data security has always been a major challenge in hospitals and research organizations as the need to collect and store data for longer time period requires high standards of efficient and scalable storage solutions. The ability to analyze digital pathology data is a key advantage of digital pathology. Storage systems are therefore essential to support data analytics and machine learning applications.
North America region held a major market share of 41% in 2022. North America has a well-established healthcare infrastructure with a large number of hospitals and diagnostic laboratories that are early adopters of advanced medical technologies, including digital pathology.
The development of advanced imaging technologies and digital pathology systems, such as whole slide imaging (WSI) and the increasing prevalence of cancer and cardiovascular diseases are some of the primary factors driving Digital Pathology market in this region
North America has a strong regulatory framework for medical devices and healthcare technologies, which provides assurance to healthcare providers and patients that digital pathology solutions meet quality and safety standards.
Cloud-based solutions can be accessed from anywhere, enabling pathologists to work remotely and collaborate with colleagues in real-time, which is particularly important in today’s globalized environment. Additionally, cloud-based solutions can easily scale up or down based on the needs of the organization, making it an attractive option for healthcare providers who want to expand their operations or reduce costs.
Implementation of technologies in digital pathology in low-resource countries such as Nigeria and Sub-Saharan Africa comes with greater difficulty as being a remote area, there is a lack of training, internet accessibility, high equipment costs, and limited access to laboratory workstations. availability of investments and budgeting for pathology is relatively small in comparison to radiology and cardiology. The decline in the rates of reimbursements has slowed down the adoption of digital pathology in the private sector. There is an overall shortage of pathological services in the region. For example, in Nigeria, 1 pathologist caters to 2 million people.
Purchase this Premium Report:
https://www.industryarc.com/purchasereport.php?id=16354
Key Opportunity Analysis:
The integration of Artificial Intelligence and Machine Learning technologies into digital pathology solutions can help to automate image analysis, improve accuracy, and speed up diagnosis. The adoption of AI and ML in digital pathology is expected to increase in the coming years, providing new opportunities for growth and innovation. Many companies are entering into collaborations and partnerships to provide optimized integrated digital pathology workflows. In March 2023, Qritive and Corista announced a partnership to advance the use of computational digital pathology workflows with integrated image management. In the same month, Paige and Leica Biosystems also announced the expansion of their digital pathology partnership to enhance use of image management and artificial intelligence technology.
Emerging markets, such as Asia-Pacific are experiencing increasing demand for healthcare services, driven by factors such as population growth, rising income levels, and increasing prevalence of chronic diseases. There is a tremendous potential for digital pathology in emerging markets to improve patient care as it eliminates the use of slides and offers better settings for higher visualization. Several new companies are entering the digital pathology market. Example- In June 2022, Roche announced the launch of its next-generation VENTANA DP 600 slide scanner for digital pathology to enhance patient care with precision diagnosis.
If you have any questions, please feel free to contact our experts at:
https://www.industryarc.com/reports/request-quote?id=16354
The Report also Covers the Following Areas:
Digital Pathology Market 2023-2030: Key Highlights
Covid and Ukrainian Crisis Impact:
To Get a Customized Industry Analysis, Speak with our Research Analyst:
https://connect.industryarc.com/lite/schedule-a-call-with-our-sales-expert
List of Key Market Players in the Digital Pathology Market:
The Global Digital Pathology Market is fragmented with several global and regional companies operating with expansive manufacturing capabilities and extensive distribution networks. The key companies profiled are listed below:
Related Reports:
Pathological Examination Market – Pathological Examination market is growing at a CAGR of 9.9% during the forecast period 2021-2026. Pathological examination is a complex process that involves many steps and is an important process for infection, genetic abnormalities, and neoplasm.
Digital Diagnostics Market – The Digital Diagnostics Market is estimated to grow at a CAGR of 14.3% during the forecast period 2022-2027. Digital Diagnostics has evolved to precisely capture, harmonize and record SARS-CoV-2 diagnostic testing data with the advent and spread of the Coronavirus (COVID-19) pandemic.
Anatomic Pathology Market – Anatomic Pathology Market is growing at a CAGR of 6.1% during the forecast period 2020-2025. Anatomical pathology is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.
About IndustryARC™:
IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format which assists an intelligent and informed decision-making process.
Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: sales@industryarc.com
USA: (+1) 970-236-3677
Web: https://www.industryarc.com
Follow us on: LinkedIn | Facebook | Twitter
Mr. Venkat Reddy IndustryARC Email: sales@industryarc.com USA: Mr. Venkat Reddy IndustryARC Email: sales@industryarc.com USA: (+1) 518-282-472
Tags:
BNN, iCN Internal Distribution, Extended Distribution, Wire, Research Newswire, English